Amneal Pharmaceuticals, Inc.

NASDAQ:AMRX

Drug Manufacturers - Specialty & Generic

Healthcare
$21.88 -0.90%

-$0.15 today

Market cap
$7.62B
Beta
1.32
P/E (TTM)
43.4
EPS (TTM)
$0.37
52W Low $7.67High $16.61

Volume 1.91M

Average 1.75M

AMRX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Amneal Pharmaceuticals, Inc.NASDAQ: AMRX

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 319.2M shares rose 1.7% year over year, in line with the +1.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.0% from the prior quarter. Over 3 fiscal years it compounded at +27.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.7% holds above the trailing-twelve-month pace of +1.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
319.2M+1.0% QoQ
Last fiscal yearDec 2025
313.37M+1.4% YoY
LTMJun 2026
315.69M+1.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.7%——
1 year+1.4%——
3-year CAGR+27.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
313.37M USD
Year-over-year change
+1.4%
4-year CAGR
+20.4%

Weighted Avg Shares vs competitors

How AMRX compares with its peers on the latest reported figures

  • AMRX's LTM Jun 2026 weighted avg shares of 315.69M shares is the 5th highest of the 11 companies compared; the peer median is 131.94M shares.
  • Its year-over-year change of +1.5% is the 3rd highest of 11, against a peer median of +0.3%.
  • Over three fiscal years its annual growth of +27.6% compares with a peer median of +0.9%.
AMRX Competitors Peer median
Weighted Avg Shares for AMRX and competitors
Company Period LTM YoY 3-year CAGR
VTRSViatris Inc.LTM Jun 20261.16B -2.4%-1.2%
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20261.15B +1.5%+1.2%
RDYDr. Reddy's Laboratories LimitedLTM Sep 2026833.5M +0.1%+0.1%
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 2026315.69M +1.5%+27.6%
PRGOPerrigo Company plcLTM Jun 2026138.7M +0.7%+1.0%
INDVIndivior Pharmaceuticals IncLTM Jun 2026125.18M -1.1%-3.5%
EBSEmergent BioSolutions Inc.LTM Mar 202652.93M -1.2%+2.2%
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202646.16M -4.6%-1.3%
ANIPANI Pharmaceuticals, Inc.LTM Mar 202620.22M +4.0%+7.2%
CPIXCumberland Pharmaceuticals Inc.LTM Mar 202614.96M +4.8%+0.9%
Peer median (excluding AMRX) 131.94M+0.3%+0.9%

Competitors are the stored peer set for AMRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.09B2.21B2.39B2.79B3.02B
Cost of Revenue1.32B1.42B1.53B1.77B1.88B
Gross Profit768.97M791.46M863.87M1.02B1.14B
Gross Margin36.7%35.8%36.1%36.5%37.6%
Research & Development209.56M208.66M194.75M190.71M186.18M
Selling, General & Admin365.5M399.7M429.68M476.44M526.83M
Operating Expenses616.26M886.39M659.5M771.11M713M
Depreciation & Amortization233.41M240.18M229.4M236.19M223.57M
EBITDA401.1M440.21M500.78M439.77M603.87M
EBITDA Margin19.2%19.9%20.9%15.7%20.0%
Operating Income152.72M(94.93M)204.37M249.33M423.09M
Operating Margin7.3%-4.3%8.5%8.9%14.0%
Interest Income00000
Interest Expense136.33M158.38M210.63M258.6M241.09M
Other Income / Expenses(121.35M)(153.2M)(244.64M)(304.34M)(283.88M)
Income Before Tax31.37M(248.13M)(40.27M)(55.01M)139.21M
Pre-Tax Margin1.5%-11.2%-1.7%-2.0%4.6%
Income Tax Expense11.2M6.66M8.45M18.86M11.28M
Net Income10.62M(129.99M)(83.99M)(116.89M)72.06M
Net Margin0.5%-5.9%-3.5%-4.2%2.4%
EPS (Basic)0.07(0.86)(0.48)(0.38)0.23
EPS (Diluted)0.07(0.86)(0.48)(0.38)0.22
Weighted Avg Shares148.92M150.94M174.99M308.98M313.37M
Weighted Avg Shares (Diluted)151.82M150.94M176.14M308.98M324.81M

Amneal Pharmaceuticals, Inc.

NASDAQ:AMRX

Intrinsic Alpha fair value

Locked

Current Price

$21.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.